Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » Blogs » ED Push » ED Program Dramatically Increases HCV Testing

    ED Push
    ED Push RSS FeedRSS

    edpush-webheader-rm

    Free Monthly News from the Award Winning Publisher of:

    • Emergency Medicine Reports
    • Trauma Reports
    • Critical Care Alert
    • ED Management
    • ED Legal Letter
    • Pediatric Emergency Medicine Reports
    • EM Reports' Study Guide 2018
    • STROKE: The Cutting Edge: 2017
    • Pediatric Trauma 2018
    • STEMI Watch 2018
     

     

    ED Program Dramatically Increases HCV Testing

    July 25, 2018
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share
    By Brenda Mooney

    For years, public health officials have urged more widespread hepatitis C virus (HCV) testing, even outside the typical high-risk population. A new study shows how EDs can play a critical role.

    Researchers created a nontargeted, opt‐out ED HCV screening and linkage-to-care program among patients at least 13 years of age undergoing phlebotomy for clinical purposes from November 2016 to January 2017. Clinicians were informed about the program through an electronic best practice advisory (BPA), which also generated order labels. Specimens were drawn in the ED for HCV antibody (Ab) and reflex confirmatory RNA tests. If tests were positive, patients were contacted to help them arrange outpatient medical visits. HCV screening was streamlined and made as efficient as possible for ED staff using information technology to build documentation of verbal informed consent into patients' electronic medical records.

    Overall, HCV Ab tests were performed on 3,808 patients, a 6,950% increase from pre-program. Of those, 13.2% tested positive, with 97.8% of those undergoing a follow‐up RNA test. Ultimately, 292 patients were confirmed positive for active infection, an overall RNA positivity rate of 7.7%.

    For the last six years, the CDC has promoted routine one-time HCV screening for individuals born between 1945 and 1965, in addition of testing for the high-risk cohort, including drug users. These authors noted that 53% of patients who tested positive for active infection in this special program were outside the CDC’s birth cohort for increased risk for HCV; additionally, 15.8% of this cohort did not report injection drug use.

    The study team tried to link patients with active infections to follow-up care; appointments were scheduled for 102 patients, and 66 patients showed up for care visits, about 22% of those testing positive.

     

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    ED Push

    View PDF
    ED Push - August 2018 Issue
    August 1, 2018

    Table Of Contents

    Sepsis Protocols Effective in Reducing Mortality

    Neuroimaging for ED Patients with Non-index Seizures

    ED Program Dramatically Increases HCV Testing

    Case Mix Differences in Freestanding vs. Hospital-based EDs

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2020 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing